The FDA's groundbreaking approval of the first natalizumab biosimilar heralds a new era in multiple sclerosis treatment, offering hope, affordability, and expanded access for patients.
Read More
The chronic nature of Multiple Sclerosis (MS), can leave devastating effects on quality of life. New research examines if Mindfulness-Based Stress Reduction (MBSR) can boost the quality of life and fatigue severity among patients with MS.
Read More